Preeclamptic nephropathy

Nephrology

Volumn 16, Issue 2, 2011, Pages 134-143

  Hennessy, Annemarie ^a   Makris, Angela ^b  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

Author keywords

anti angiogensis factor; nephropathy; preeclampsia

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; BIOLOGICAL MARKER; CREATININE; ENDOGLIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DISEASE SEVERITY; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY VASCULAR RESISTANCE; MATERNAL HYPERTENSION; PODOCYTE; PREECLAMPSIA; PREECLAMPTIC NEPHROPATHY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URINALYSIS; URINARY EXCRETION;

ANIMALS; BIOLOGICAL MARKERS; FEMALE; HUMANS; KIDNEY DISEASES; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 79551538306     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01411.x     Document Type: Review

References (103)

1. Lowe SA, Brown MA, Dekker GA, et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust. N.Z. J. Obstet. Gynaecol. 2009; 49: 242-6.
2. Lenfant C,; National Education Program Working Group on High Blood Pressure in Pregnancy. Working group report on high blood pressure in pregnancy. J. Clin. Hypertens. (Greenwich) 2001; 3: 75-88.
3. Davison JM, Dunlop W,. Renal hemodynamics and tubular function normal human pregnancy. Kidney Int. 1980; 18: 152-61.
4. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998; 54: 2056-63.
5. Schrier RW, Briner VA,. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: Implications for pathogenesis of preeclampsia-eclampsia. Obstet. Gynecol. 1991; 77: 632-9.
6. Smith MC, Moran P, Ward MK, Davison JM,. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG 2008; 115: 109-12.
7. Wilson M, Morganti AA, Zervoudakis I, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am. J. Med. 1980; 68: 97-104.
8. Baylis C, Davison JM,. The urinary system. In:, Chamberlain G, Btroughton-Pipkin F, (eds). Clinical Physiology in Obstetrics, 3rd edn. London: Blackwell Science, 1998; 263-307.
9. Sims EA, Krantz KE,. Serial studies of renal function. During pregnancy and the puerperium in normal women. J. Clin. Invest. 1958; 37: 1764-74.
10. Quadri KH, Bernardini J, Greenberg A, Laifer S, Syed A, Holley JL,. Assessment of renal function during pregnancy using a random urine protein to creatinine ratio and Cockcroft-Gault formula. Am. J. Kidney Dis. 1994; 24: 416-20.
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK,. Preeclampsia: An endothelial cell disorder. Am. J. Obstet. Gynecol. 1989; 161: 1200-204.
12. Keiseb J, Moodley J, Connolly CA,. Comparison of the efficacy of continuous furosemide and low-dose dopamine infusion in preeclampsia/eclampsia- related oliguria in the immediate postpartum period. Hypertens. Pregnancy 2002; 21: 225-34.
13. Sullivan E, Hall B, King J,. Maternal Deaths in Australia: 2003-2005. Canberra: Australian Institute of Health and Welfare, 2008.
14. Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y,. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren. Fail. 2004; 26: 557-62.
15. Hladunewich MA, Myers BD, Derby GC, et al. Course of preeclamptic glomerular injury after delivery. Am. J. Physiol. Renal Physiol. 2008; 294: F614-20.
16. Lafayette RA, Druzin M, Sibley R, et al. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int. 1998; 54: 1240-49.
17. Moran P, Baylis PH, Lindheimer MD, Davison JM,. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J. Am. Soc. Nephrol. 2003; 14: 648-52.
18. Côté AM, Brown MA, Lam E, et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: Systematic review. BMJ 2008; 336: 1003-6.
19. Harlow FH, Brown MA,. The diversity of diagnoses of preeclampsia. Hypertens. Pregnancy 2001; 20: 57-67.
20. Al RA, Borekci B, Yapca O, Keles S, Kadanali S,. Albumin/creatinine ratio for prediction of 24-hour albumin excretion of >or =2 g in manifest preeclampsia. Clin. Exp. Obstet. Gynecol. 2009; 36: 169-72.
21. Wikström AK, Wikström J, Larsson A, Olovsson M,. Random albumin/creatinine ratio for quantification of proteinuria in manifest pre-eclampsia. BJOG 2006; 113: 930-34.
22. Khashia KM, Willett MJ, Elgawly RM,. A 24-hour urine collection for proteinuria in pregnancy: Is it worthwhile doing the test? J. Obstet. Gynaecol. 2007; 27: 388-9.
23. Oparil S, Haber E,. The renin-angiotensin system (second of two parts). N. Engl. J. Med. 1974; 291: 446-57.
24. Irani RA, Xia Y,. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008; 29: 763-71.
25. Herse F, Dechend R, Harsem NK, et al. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007; 49: 604-11.
26. Gallery ED, Hunyor SN, Györy AZ,. Plasma volume contraction: A significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q. J. Med. 1979; 48: 593-602.
27. Escher G, Mohaupt M,. Role of aldosterone availability in preeclampsia. Mol. Aspects Med. 2007; 28: 245-54.
28. Brown MA, Zammit VC, Mitar DM,. Extracellular fluid volumes inpregnancy-induced hypertension. J. Hypertens. 1992; 10: 61-8.
29. Vaughan CJ, Delanty N,. Hypertensive emergencies. Lancet 2000; 356: 411-17.
30. Roberts JM, Myatt L, Spong CY, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N. Engl. J. Med. 2010; 362: 1282-91.
31. Baker PN, Krasnow J, Roberts JM, Yeo KT,. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet. Gynecol. 1995; 86: 815-21.
32. Simmons LA, Hennessy A, Gillin AG, Jeremy RW,. Uteroplacental blood flow and placental vascular endothelial growth factor in normotensive and pre-eclamptic pregnancy. BJOG 2000; 107: 678-85.
33. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003; 111: 649-58.
34. Zhao S, Gu X, Groome LJ, Wang Y,. Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod. Sci. 2009; 16: 970-79.
35. Makris A, Thornton C, Thompson J, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 2007; 71: 977-84.
36. LaMarca B, Speed J, Fournier L, et al. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: Effect of tumor necrosis factor-alpha blockade. Hypertension 2008; 52: 1161-7.
37. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004; 350: 672-83.
38. Levine RJ, Lam C, Qian C, et al.; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 2006; 355: 992-1005.
39. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 2006; 12: 642-9.
40. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 1999; 103: 945-52.
41. Hubel CA, Wallukat G, Wolf M, et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007; 49: 612-17.
42. Brown MA,. The physiology of pre-eclampsia. Clin. Exp. Pharmacol. Physiol. 1995; 22: 781-91.
43. LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP,. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008; 52: 1168-72.
44. Zhou CC, Zhang Y, Irani RA, et al. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008; 14: 855-62.
45. Spargo B, Mccartney CP, Winemiller R,. Glomerular capillary endotheliosis in toxemia of pregnancy. Arch. Pathol. 1959; 68: 593-9.
46. Kincaid-Smith P,. The renal lesion of preeclampsia revisited. J. Kidney Dis. 1991; 17: 144-8.
47. Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol. Dial. Transplant. 2007; 22: 1136-43.
48. Sheehan HL,. Renal morphology in preeclampsia. Kidney Int. 1980; 18: 241-52.
49. Strevens H, Wide-Swensson D, Hansen A, et al. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003; 110: 831-6.
50. Wide-Swensson D, Strevens H, Willner J,. Antepartum percutaneous renal biopsy. Int. J. Gynaecol. Obstet. 2007; 98: 88-92.
51. Packham DK, North RA, Fairley KF, Kloss M, Whitworth JA, Kincaid-Smith P,. Primary glomerulonephritis and pregnancy. Q. J. Med. 1989; 71: 537-53.
52. Hulstein JJ, van Runnard Heimel PJ, Franx A, et al. Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J. Thromb. Haemost. 2006; 4: 2569-75.
53. Redman CW, Sargent IL,. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008; 29 (Suppl A): S73-7.
54. González-Quintero VH, Smarkusky LP, Jiménez JJ, et al. Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension. Am. J. Obstet. Gynecol. 2004; 191: 1418-24.
55. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J,. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 2005; 16: 1733-41.
56. Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 2007; 196: 320. e1-7.
57. Aita K, Etoh M, Hamada H, et al. Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron. Clin. Pract. 2009; 112: c65-70.
58. Karumanchi SA, Lindheimer MD,. Preeclampsia and the kidney: Footprints in the urine. Am. J. Obstet. Gynecol. 2007; 196: 287-8.
59. Hauser PV, Collino F, Bussolati B, Camussi G,. Nephrin and endothelial injury. Curr. Opin. Nephrol. Hypertens. 2009; 18: 3-8.
60. Henao DE, Arias LF, Mathieson PW, et al. Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron. Exp. Nephrol. 2008; 110: e73-81.
61. Collino F, Bussolati B, Gerbaudo E, et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am. J. Physiol. Renal Physiol. 2008; 294: F1185-94.
62. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA,. Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 2006; 168: 639-48.
63. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W,. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell. Biol. 1998; 140: 947-59.
64. Eremina V, Sood M, Haigh J, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 2003; 111: 707-16.
65. Satchell SC, Braet F,. Glomerular endothelial cell fenestrations: An integral component of the glomerular filtration barrier. Am. J. Physiol. Renal Physiol. 2009; 296: F947-56.
66. Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J. Biol. Chem. 2003; 278: 12605-8.
67. Orange S, Rasko JE, Thompson JF, et al. Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 2005; 29: 176-85.
68. Xing Y, Ding J, Fan Q, Guan N,. Diversities of podocyte molecular changes induced by different antiproteinuria drugs. Exp. Biol. Med. (Maywood) 2006; 231: 585-93.
69. Liang XB, Ma LJ, Naito T, et al. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J. Am. Soc. Nephrol. 2006; 17: 1886-95.
70. Gallery ED,. Chronic essential and secondary hypertension in pregnancy. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 1999; 13: 115-30.
71. Brown MA, Whitworth JA,. Management of hypertension in pregnancy. Clin. Exp. Hypertens. 1999; 21: 907-16.
72. Redman CW, Sargent IL,. Placental stress and pre-eclampsia: A revised view. Placenta 2009; 30 (Suppl A): S38-42.
73. Jefferys A, Wyburn K, Chow J, Cleland B, Hennessy A,. Peritoneal dialysis in pregnancy: A case series. Nephrology (Carlton) 2008; 13: 380-83.
74. Bolignano D, Coppolino G, Crascì E, Campo S, Aloisi C, Buemi M,. Pregnancy in uremic patients: An eventful journey. J. Obstet. Gynaecol. Res. 2008; 34: 137-43.
75. Vikse BE, Irgens LM, Bostad L, Iversen BM,. Adverse perinatal outcome and later kidney biopsy in the mother. J. Am. Soc. Nephrol. 2006; 17: 837-45.
76. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM,. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 2008; 359: 800-809.
77. Gaber LW, Spargo BH,. Pregnancy-induced nephropathy: The significance of focal segmental glomerulosclerosis. Am. J. Kidney Dis. 1987; 9: 317-23.
78. Packham DK, North RA, Fairley KF, Kloss M, Whitworth JA, Kincaid-Smith P,. Primary glomerulonephritis and pregnancy. Q. J. Med. 1989; 71: 537-53.
79. Hamano T,. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat. Clin. Pract. Nephrol. 2009; 5: 8-9.
80. Heaton JM, Turner DR,. Persistent renal damage following pre-eclampsia: A renal biopsy study of 13 patients. J. Pathol. 1985; 147: 121-6.
81. Reisætera AV, Røislienb J, Henriksenc T, Irgensd LM, Hartmanna A,. Pregnancy and birth after kidney donation: The norwegian experience. Am. J. Transplant. 2009; 9: 820-24.
82. Ibrahim HN, Akkina SK, Leister E, et al. Pregnancy outcomes after kidney donation. Am. J. Transplant. 2009; 9: 825-34.
83. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R,. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet. Gynecol. Scand. 2008; 87: 837-42.
84. Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV,. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am. J. Obstet. Gynecol. 2008; 199: 266. e1-6.
85. Savvidou MD, Akolekar R, Zaragoza E, Poon LC, Nicolaides KH,. First trimester urinary placental growth factor and development of pre-eclampsia. BJOG 2009; 116: 643-7.
86. Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V,. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 2006; 69: 621-4.
87. Levine RJ, Thadhani R, Qian C, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005; 293: 77-85.
88. Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH,. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat. Diagn. 2009; 29: 1103-8.
89. Sataboulidou I, Galindo A, Maiz N, Karagiannis G, Nicolaides KH,. First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects. Fetal. Diagn. Ther. 2009; 25: 336-9.
90. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM,. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod. Sci. 2008; 15: 374-81.
91. Stenczer B, Rigõ J Jr, Prohászka Z, et al. Plasma osteopontin concentrations in preeclampsia-is there an association with endothelial injury? Clin. Chem. Lab. Med. 2010; 48: 181-7.
92. Strevens H, Wide-Swensson D, Grubb A, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG 2003; 110: 825-30.
93. Woolcock J, Hennessy A, Xu B, et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust. N.Z. J. Obstet. Gynaecol. 2008; 48: 64-70.
94. Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K,. Nephron number, hypertension, renal disease, and renal failure. J. Am. Soc. Nephrol. 2005; 16: 2557-64.
95. Spaan JJ, Ekhart T, Spaanderman ME, Peeters LL,. Remote hemodynamics and renal function in formerly preeclamptic women. Obstet. Gynecol. 2009; 113: 853-9.
96. Chesley LC,. Recognition of the long-term sequelae of eclampsia. Am. J. Obstet. Gynecol. 2000; 182: 249-50.
97. Bellamy L, Casas JP, Hingorani AD, Williams DJ,. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007; 335: 974.
98. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ,. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am. Heart J. 2008; 156: 91n8-30.
99. Thornton CE, von Dadelszen P, Makris A, Tooher JM, Ogle RF, Hennessy A,. Acute pulmonary oedema as a complication of hypertension during pregnancy. Hypertens. Pregnancy 2009; [Epub ahead of print]. doi:10.3109/10641950902972140
100. Fairley KF, Kincaid-Smith P,. Renal disease in pregnancy. Postgrad. Med. J. 1968; 44: 45-8.
101. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA,. Cardiovascular health after maternal placental syndromes (CHAMPS): Population-based retrospective cohort study. Lancet 2005; 366: 1797-803.
102. Groom KM, North RA, Stone PR, et al.; SCOPE Consortium. Patterns of change in uterine artery Doppler studies between 20 and 24 weeks of gestation and pregnancy outcomes. Obstet. Gynecol. 2009; 113 (2 Pt 1): 332-8.
103. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ,. Weight in infancy and death from ischaemic heart disease. Lancet 1989; 2: 577-80.